London, 24 September 2014: TechNavio, the independent tech-focused global research firm, has published a report on the Global Bariatric Surgery Devices Market 2014-2018, which is expected to grow at a CAGR of 8.21 percent during the period 2013-2018.
Bariatric surgery is the treatment procedure used to treat obesity. The use of a particular bariatric surgery device depends on the type of bariatric procedure being performed.
“With improvements in surgical techniques and devices along with the novel compelling application of bariatric surgery for the treatment of severe metabolic disorders, the revision of failed procedures is expected to increase considerably during the forecast period,” says Faisal Ghaus, Vice President of TechNavio.
“A revision surgery may improve intolerable symptoms caused by the primary surgery, help increase weight loss, and also help in the management of obesity-associated disorders such as high blood pressure, diabetes, and high cholesterol.”
Key Market Drivers
- Increase in Prevalence of Obesity
- Growing Prevalence of Type 2 Diabetes
- Rise in Customer Awareness
- High Adoption of MI Surgery
Key Market Trends
- Increasing Popularity of Sleeve Gastrectomy
- Growing Use of Revision Surgery
- Rise in Medical Tourism in Emerging Countries
Key Market Vendors
- Allergan Inc.
- Covidien plc
- Johnson & Johnson
- Olympus Corp.
To define the market circumstances in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
